MTOR and fleck corneal dystrophy: Our understanding of the molecular basis of FCD has changed dramatically during the past ten years, particularly for FCD ILAE Type 2, with ample scientific evidence for pathogenic and epileptogenic brain somatic mutations in genes of the mTOR pathway [3, 25, 29].